Big Pharma Split Corp Class A - Equity (PRM)

CUSIP: L7579L106

Q1 2022 13F Holders as of 31 Mar 2022

Share change
-2,685,048
SEC-reported price per share
$12.11
Number of holders
67
Value change
-$34,540,812
Number of buys
41
Number of sells
22

Security key

L7579L106

Report period

Q1 2022

Institutions

67

Top holders

10

Ownership snapshot

Top reported holders of PRM - Big Pharma Split Corp Class A - Equity (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WINDACRE PARTNERSHIP LLC
Disclosed value leader
WINDACRE PARTNERSHIP LLC
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $277,800,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WINDACRE PARTNERSHIP LLC has the largest disclosed position value at $277.8M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WINDACRE PARTNERSHIP LLC's linked filing trail.
Disclosed position value Top 5
WINDACRE PARTNERSHIP LLC $277.8M
Select Equity Group, L.P. $194.17M
Tiger Eye Capital LLC $147.08M
TIGER GLOBAL MANAGEMENT LLC $138.9M
Capital Research Global Investors $128.63M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WINDACRE PARTNERSHIP LLC
13F
Company
13F
—
denominator unverified
$277,800,000
20,000,000 shares
— 31 Dec 2021
Select Equity Group, L.P.
13F
Company
13F
—
denominator unverified
$194,166,000
13,978,869 shares
— 31 Dec 2021
Tiger Eye Capital LLC
13F
Company
13F
—
denominator unverified
$147,085,000
10,589,302 shares
— 31 Dec 2021
TIGER GLOBAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$138,900,000
10,000,000 shares
— 31 Dec 2021
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$128,628,000
9,260,505 shares
— 31 Dec 2021
PRINCIPAL FINANCIAL GROUP INC
13F
Company
13F
—
denominator unverified
$128,192,000
9,229,126 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
67
Shares
147,051,941
Rows available
67
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q2 2026 Across Filers

Q2 2026 holders
3
Q1 2022 holders
67
Holder diff
64
Investor Q2 2026 Shares Q1 2022 Shares Share Diff Share Chg % Q2 2026 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .